Cargando…
Liposomal Encapsulated FSC231, a PICK1 Inhibitor, Prevents the Ischemia/Reperfusion-Induced Degradation of GluA2-Containing AMPA Receptors
Strokes remain one of the leading causes of disability within the United States. Despite an enormous amount of research effort within the scientific community, very few therapeutics are available for stroke patients. Cytotoxic accumulation of intracellular calcium is a well-studied phenomenon that o...
Autores principales: | Achzet, Lindsay M., Astruc-Diaz, Fanny, Beske, Phillip H., Natale, Nicholas R., Denton, Travis T., Jackson, Darrell A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146086/ https://www.ncbi.nlm.nih.gov/pubmed/33946313 http://dx.doi.org/10.3390/pharmaceutics13050636 |
Ejemplares similares
-
FSC231 alleviates paclitaxel‐induced neuralgia by inhibiting the interactions between PICK1 and GluA2 and activates GSK‐3β and ERK1/2
por: Zhang, Xi, et al.
Publicado: (2021) -
Activity-Dependent Ubiquitination of GluA1 and GluA2 Regulates AMPA Receptor Intracellular Sorting and Degradation
por: Widagdo, Jocelyn, et al.
Publicado: (2015) -
Postsynaptic VAMP/Synaptobrevin Facilitates Differential Vesicle Trafficking of GluA1 and GluA2 AMPA Receptor Subunits
por: Hussain, Suleman, et al.
Publicado: (2015) -
Roles of the AMPA receptor subunit GluA1 but not GluA2 in synaptic potentiation and activation of ERK in the anterior cingulate cortex
por: Toyoda, Hiroki, et al.
Publicado: (2009) -
ABA Renewal Involves Enhancements in Both GluA2-Lacking AMPA Receptor Activity and GluA1 Phosphorylation in the Lateral Amygdala
por: Park, Kyungjoon, et al.
Publicado: (2014)